We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.33%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.06B
AUM Growth
+$85.4M
Cap. Flow
-$112M
Cap. Flow %
-2.21%
Top 10 Hldgs %
24.32%
Holding
813
New
65
Increased
293
Reduced
256
Closed
67

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$54.2M
2
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
+$47.4M
3
NKE icon
Nike
NKE
+$36.3M
4
ABBV icon
AbbVie
ABBV
+$33.2M
5
ICLR icon
Icon
ICLR
+$31.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.61%
2 Technology 15.85%
3 Consumer Discretionary 14.66%
4 Financials 12.36%
5 Communication Services 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHG icon
226
InterContinental Hotels
IHG
$24B
$1.48M 0.03%
35,782
+80
+0.2% +$3.74K
IVR.PRB
227
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
$1.46M 0.03%
59,660
-800
-1% -$19K
DCM
228
DELISTED
NTT DOCOMO, Inc.
DCM
$1.45M 0.03%
+53,585
New +$1.34M
VRTX icon
229
Vertex Pharmaceuticals
VRTX
$139B
$1.42M 0.03%
16,455
+13,852
+532% +$1.2M
EOG icon
230
EOG Resources
EOG
$75.8B
$1.41M 0.03%
16,910
+525
+3% +$42.1K
PX
231
DELISTED
Praxair Inc
PX
$1.41M 0.03%
12,551
-100
-0.8% -$11.3K
TM icon
232
Toyota
TM
$227B
$1.41M 0.03%
14,067
-20
-0.1% -$2.05K
LKQ icon
233
LKQ Corp
LKQ
$6.42B
$1.4M 0.03%
44,268
-2,258
-5% -$73.4K
UNH icon
234
UnitedHealth
UNH
$355B
$1.37M 0.03%
9,703
+119
+1% +$15.9K
ROK icon
235
Rockwell Automation
ROK
$48.1B
$1.37M 0.03%
11,902
-80
-0.7% -$9.16K
JCI icon
236
Johnson Controls International
JCI
$86.1B
$1.34M 0.03%
29,020
-1,793
-6% -$79K
SPSC icon
237
SPS Commerce
SPSC
$3.03B
$1.34M 0.03%
44,390
+7,864
+22% +$204K
XNCR icon
238
Xencor
XNCR
$2.15B
$1.32M 0.03%
69,555
-6,200
-8% -$85K
CL icon
239
Colgate-Palmolive
CL
$72.5B
$1.28M 0.03%
17,496
-1,680
-9% -$120K
IEV icon
240
iShares Europe ETF
IEV
$1.7B
$1.28M 0.03%
33,864
+844
+3% +$33.1K
LYB icon
241
LyondellBasell Industries
LYB
$20.4B
$1.28M 0.03%
17,204
-473
-3% -$39K
SNN icon
242
Smith & Nephew
SNN
$12.2B
$1.26M 0.02%
36,717
+257
+0.7% +$8.69K
WAGE
243
DELISTED
WageWorks, Inc.
WAGE
$1.24M 0.02%
20,775
-1,812
-8% -$100K
ENV
244
DELISTED
ENVESTNET, INC.
ENV
$1.24M 0.02%
37,238
-10,065
-21% -$325K
HII icon
245
Huntington Ingalls Industries
HII
$11.7B
$1.23M 0.02%
7,330
+1,803
+33% +$274K
LEG icon
246
Leggett & Platt
LEG
$1.26B
$1.23M 0.02%
24,025
-531
-2% -$26.1K
RIO icon
247
Rio Tinto
RIO
$170B
$1.22M 0.02%
39,063
+2,353
+6% +$70.3K
PTR
248
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$1.21M 0.02%
17,786
+311
+2% +$21.4K
NFX
249
DELISTED
Newfield Exploration
NFX
$1.2M 0.02%
27,245
+1,130
+4% +$43.4K
TEVA icon
250
Teva Pharmaceuticals
TEVA
$43.8B
$1.19M 0.02%
23,765
-8,328
-26% -$443K

Similar funds

Geneva Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Geneva Advisors held 813 positions worth $5.06B, up 1.7% from $4.97B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Geneva Advisors's Q2 2016 filing shows 65 new, 293 increased, 256 reduced and 67 closed positions. Its largest new stake was S&P Global: 484,514 shares worth $52M. The largest sale was Boeing, an estimated $54.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q2 2016 buy was S&P Global: 484,514 shares worth $52M.
  • Geneva Advisors added most to Intuitive Surgical in Q2 2016, an estimated $30.7M increase.
  • Geneva Advisors's biggest Q2 2016 reduction was Boeing, cutting an estimated $54.2M.
  • Geneva Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $47.4M.
  • Geneva Advisors's ten largest holdings make up 24% of its $5.06B portfolio in Q2 2016.
  • Geneva Advisors opened 65 new positions and closed 67 in Q2 2016.
  • Geneva Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.06B.

Based on Geneva Advisors's 13F filing for Q2 2016, filed 8 Aug 2016.